Acquiring Company
InterCure Ltd. (dba Canndoc)
Acquired Company
Leon Pharm Ltd
HerzliyaTel AvivPharmaceutical ManufacturingBiotechnologyHealth CareMedicalCannabisDescription
InterCure Ltd. (dba Canndoc), the leading medical cannabis company in Israel and outside of North America, has entered into a share purchase agreement with the shareholders of Leon Pharm Ltd. to purchase Leon Pharm, a leading, Israel-based pharmacy chain specializing in dispensing medical cannabis in Israel. This acquisition is consistent with InterCure's strategy of expanding its market-leading distribution network towards the new medical cannabis reform announced by the Israeli Ministry of Health and is expected to be accretive to the Company’s business model.
Quick answer
InterCure Ltd. (dba Canndoc) is acquiring Leon Pharm Ltd, announced January 31, 2024. InterCure Ltd. (dba Canndoc) is based in Herzliya, Tel Aviv, Israel.
- How much did InterCure Ltd. (dba Canndoc) pay for Leon Pharm Ltd?
- The deal value was not disclosed.
- What does InterCure Ltd. (dba Canndoc) do?
- InterCure Ltd. (dba Canndoc) is the leading medical cannabis company in Israel and outside of North America.
- Where are InterCure Ltd. (dba Canndoc) and Leon Pharm Ltd based?
- InterCure Ltd. (dba Canndoc) is based in Herzliya, Tel Aviv, Israel. Leon Pharm Ltd is based in Tel Aviv, Tel Aviv District, Israel.
Source: Fundz verified event record.
Other recent acquisitions in Pharmaceutical Manufacturing and Medical
Deals where the buyer or target shares a sector with this one, within 45 days, from Fundz verified event records.
- Elevance Health completes acquisition of Paragon Healthcare to enhance specialty medication access (March 11, 2024)
- XOMA Enters into Agreement to Acquire Kinnate Biopharma for Between $2.3352 and $2.5879 in Cash Per Share Plus a Contingent Value Right (February 16, 2024)
- Aurora Cannabis Acquires MedReleaf Australia (February 8, 2024)
- Myriad Genetics to Acquire Precise Tumor, Precise Liquid and Laboratory from Intermountain Precision Genomics (January 18, 2024)
- Astellas Completes Acquisition Of Propella Therapeutics (December 21, 2023)
- Novartis completes acquisition of IFM Due to develop first-in-class STING antagonist program targeting innate immune system (March 13, 2024)
Who to call at InterCure Ltd. (dba Canndoc), and when
When InterCure Ltd. (dba Canndoc) changes hands, the new owners review vendors, systems and leadership. That is when the door opens.
- An alert the day InterCure Ltd. (dba Canndoc) raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at InterCure Ltd. (dba Canndoc), from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at InterCure Ltd. (dba Canndoc). With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment InterCure Ltd. (dba Canndoc) makes an acquisition, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Frequently asked
Who acquired Leon Pharm Ltd?
Leon Pharm Ltd was acquired by InterCure Ltd. (dba Canndoc), based in Herzliya. The deal was reported on January 31, 2024. InterCure Ltd. (dba Canndoc) is the leading medical cannabis company in Israel and outside of North America. InterCure Ltd. (dba Canndoc) is privately held and operates in Pharmaceutical Manufacturing.
When did InterCure Ltd. (dba Canndoc) acquire Leon Pharm Ltd?
InterCure Ltd. (dba Canndoc)'s acquisition of Leon Pharm Ltd was reported on January 31, 2024. InterCure Ltd. (dba Canndoc), the leading medical cannabis company in Israel and outside of North America, has entered into a share purchase agreement with the shareholders of Leon Pharm Ltd. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.
What does Leon Pharm Ltd do?
Leon Pharm Ltd. is a leading Israel-based pharmacy chain specializing in dispensing medical cannabis in Israel. It is privately held, operating in Biotechnology, and is based in Tel Aviv.
This company was part of an acquisition. Fundz tracks who bought whom, and who to call on both sides.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.